Cargando…

Neurodevelopmental Outcomes in Infants with Retinopathy of Prematurity and Bevacizumab Treatment

PURPOSE: The current study aims to investigate the neurodevelopment of premature infants after intravitreal injections of bevacizumab (IVB) for the treatment of retinopathy of prematurity (ROP) up to the age of 2 years. METHODS: The study design was retrospective observational case series conducted...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lien, Reyin, Yu, Mu-Hsien, Hsu, Kuang-Hung, Liao, Pei-Ju, Chen, Yen-Po, Lai, Chi-Chun, Wu, Wei-Chi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4729687/ https://www.ncbi.nlm.nih.gov/pubmed/26815000 http://dx.doi.org/10.1371/journal.pone.0148019

Ejemplares similares

Involution of retinopathy of prematurity and neurodevelopmental outcomes after intravitreal bevacizumab treatment
por: Chang, Yu-Shan, et al.
Publicado: (2019)

Neurocritical care of premature infants
por: Lien, Reyin
Publicado: (2020)

Neurodevelopmental outcomes following intravitreal bevacizumab injection in Japanese preterm infants with type 1 retinopathy of prematurity
por: Arima, Mitsuru, et al.
Publicado: (2020)

Systemic Cytokines in Retinopathy of Prematurity
por: Wu, Po-Yi, et al.
Publicado: (2023)

Postnatal Growth Trajectories and Neurodevelopmental Outcomes Following Bevacizumab Treatment for Retinopathy of Prematurity
por: Zhang, David L, et al.
Publicado: (2022)

Intravitreal Injection of Bevacizumab for Retinopathy of Prematurity in an Infant with Peters Anomaly
por: Minami, Tsuyoshi, et al.
Publicado: (2014)

Pulmonary function in school-age children following intravitreal injection of bevacizumab for retinopathy of prematurity
por: Huang, Ching-Yen, et al.
Publicado: (2022)

Growth and neurodevelopmental status in patients with retinopathy of prematurity treated with intravitreal bevacizumab: a case–control study
por: Abrishami, Majid, et al.
Publicado: (2021)

Associations of VEGF Polymorphisms With Retinopathy of Prematurity
por: Ling, Xiao Chun, et al.
Publicado: (2023)

Inhalation Anesthesia with Sevoflurane during Intravitreal Bevacizumab Injection in Infants with Retinopathy of Prematurity
por: Tokgöz, Orhan, et al.
Publicado: (2013)

Neurodevelopmental outcomes in very low birthweight infants with retinopathy of prematurity in a nationwide cohort study
por: Ahn, Ja-Hye, et al.
Publicado: (2022)

Bevacizumab or laser for aggressive posterior retinopathy of prematurity
por: Blair, Michael, et al.
Publicado: (2018)

Retinopathy of prematurity and neurodevelopmental outcomes in preterm infants: A systematic review and meta-analysis
por: Diggikar, Shivashankar, et al.
Publicado: (2023)

Refractive and Biometric Outcomes in Patients with Retinopathy of Prematurity Treated with Intravitreal Injection of Ranibizumab as Compared with Bevacizumab: A Clinical Study of Correction at Three Years of Age
por: Chen, Yen-Chih, et al.
Publicado: (2018)

Severe Retinopathy of Prematurity Associated With Neurodevelopmental Disorder in Children
por: Choi, Young-Jin, et al.
Publicado: (2022)

Comment on “bevacizumab or laser for aggressive posterior retinopathy of prematurity”
por: Samanta, Ramanuj
Publicado: (2019)

Effect of intravitreal bevacizumab for retinopathy of prematurity on weight gain
por: Obata, Shumpei, et al.
Publicado: (2021)

Foveal hypoplasia and characteristics of optical components in patients with familial exudative vitreoretinopathy and retinopathy of prematurity
por: Chen, Pei-Ying, et al.
Publicado: (2022)

Effects of TIMP-2 Polymorphisms on Retinopathy of Prematurity Risk, Severity, Recurrence, and Treatment Response
por: Wu, Pei-Liang, et al.
Publicado: (2022)

Analysis of Brain Injury Biomarker Neurofilament Light and Neurodevelopmental Outcomes and Retinopathy of Prematurity Among Preterm Infants
por: Sjöbom, Ulrika, et al.
Publicado: (2021)

Incidence of Retinopathy of Prematurity in Extremely Premature Infants
por: Şahin, Alparslan, et al.
Publicado: (2014)

Axial length, refraction, and retinal vascularization 1 year after ranibizumab or bevacizumab treatment for retinopathy of prematurity
por: Lin, Chun-Ju, et al.
Publicado: (2016)

Reply to comment on: “Advantages of bevacizumab for aggressive posterior retinopathy of prematurity”
por: Schechet, Sidney A., et al.
Publicado: (2019)

Comparison of aflibercept and bevacizumab in the treatment of type 1 retinopathy of prematurity
por: Riazi-esfahani, Hamid, et al.
Publicado: (2021)

Evaluation of babies with retinopathy of prematurity following intravitreal bevacizumab administration
por: Sahin, Ozlem, et al.
Publicado: (2023)

Refractive profile of children treated with intravitreal bevacizumab for retinopathy of prematurity
por: Pawar, Neelam, et al.
Publicado: (2023)

Retinopathy of prematurity like retinopathy in full-term infants
por: Ratra, Dhanashree, et al.
Publicado: (2017)

Comparison of RetCam and Smartphone-Based Photography for Retinopathy of Prematurity Screening
por: Lin, Jui-Yen, et al.
Publicado: (2022)

Early Experience with Intravitreal Bevacizumab Combined with Laser Treatment for Retinopathy of Prematurity
por: Raizada, Seemant, et al.
Publicado: (2011)

Early Experience with Intravitreal Bevacizumab Combined with Laser Treatment for Retinopathy of Prematurity
por: Ahmed, Ayesha E., et al.
Publicado: (2010)

Ocular and Systemic Results of Intravitreal Bevacizumab Injection in Retinopathy of Prematurity Treatment
por: Cevik, Sadik Gorkem, et al.
Publicado: (2020)

Angiographic Review of Choroidal Involution in Eyes with Retinopathy of Prematurity Treated with Bevacizumab
por: Islam, Yasmin, et al.
Publicado: (2020)

The Severity of Retinopathy in the Extremely Premature Infants
por: Trivli, Alexandra, et al.
Publicado: (2017)

Association of Severe Retinopathy of Prematurity and Bronchopulmonary Dysplasia with Adverse Neurodevelopmental Outcomes in Preterm Infants without Severe Brain Injury
por: Bae, Seong Phil, et al.
Publicado: (2021)

Aggressive Posterior Retinopathy of Prematurity in a Premature Male Infant
por: Zhou, Jun, et al.
Publicado: (2017)

Differential Effects of the Retinopathy of Prematurity Exam on the Physiology of Premature Infants
por: Tan, John B. C., et al.
Publicado: (2019)

Severe Retinopathy of Prematurity Is Not Independently Associated With Worse Neurodevelopmental Outcomes in Preterm Neonates
por: Altendahl, Marie, et al.
Publicado: (2021)

Association between severe retinopathy of prematurity (ROP) and poor motor neurodevelopmental outcome
por: Godugu, Swathi, et al.
Publicado: (2023)

Efficacy of Intravitreal Bevacizumab for the Treatment of Zone I Type 1 Retinopathy of Prematurity
por: Karkhaneh, Reza, et al.
Publicado: (2018)

Aggressive Posterior Retinopathy of Prematurity: Long-Term Outcomes Following Intravitreal Bevacizumab
por: Naravane, Ameay V., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_24ev17nomq2ku928p9dmih5tvp